Cite

HARVARD Citation

    Cetin, B. et al. (n.d.). Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO). Journal of chemotherapy. pp. 300-305. [Online]. 
  
Back to record